• Change country/language

    Looks like you’re in {} — you’re on the {} site.

    Cancel

    Country and language selected

    You are being redirected to the {} site. Products and services availability vary by country. Do you wish to continue?

    Continue
    Cancel

SenoBright HD

Illuminating breast cancer detection

 

phone-icon1800-102-2977

duct-categories-mammography-mammography-new-seno-bright-hd-banner-senobright-hd_banner.jpg

Illuminating breast cancer detection.

 

SenoBright™ HD, Contrast Enhanced Spectral Mammography (CESM) can be used as an alternative to Breast MRI to enhance the Breast care pathway.

With high specificity and sensitivity you can reduce the number of unnecessary biopsies and surgeries1

Next Generation SenoBright HD CESM is now available with Senographe Pristina.

Increase your diagnostic mammogram confidence

By highlighting unusual blood flow during the breast exam you have more information to help you get the answers you need for breast cancer diagnosis.
 

 

 

High Specificity

SenoBright HD provides high specificity to reduce false-positives and help prevent unnecessary exams

 

 

High Senstivity

 

SenoBright HD provides high specificity to reduce false-positives and help prevent unnecessary exams

 

 

Clear Image Quality

 

SenoBright HD delivers clear image quality to enhance diagnostic confidence.

SenoBright HD significantly reduces acquisition time by up to 40%  in large breasts, reducing motion artifacts on images, compared to the first generation of Contrast-enhanced Mammography.

The new Senographe Pristina grid and enhanced algorithm also limit scattered radiation and minimize artifacts.

SenoBright HD delivers improved image quality and visualization of abnormalities.

Reduce your diagnostic cost

SenoBright HD is a cost effective alternative to Breast MRI, reducing equipment costs by 53% and freeing up MRI time for other procedures4.

  • Benefit from an affordable complementary exam that reduces unnecessary exams and frees up time on your other imaging systems
  • SenoBright HD is a less expensive alternative diagnostic method.
  • Its high specificity helps you reduce unnecessary biopsies and surgeries, while freeing up MRI time for other exams.

Augment clinical capabilities

  • Facilities without an MRI don't need to invest in expensive technology or refer patients outside your health system.
  • SenoBright HD is a cost-effective alternative to help you reach a confident diagnosis.

Alleviate strains on budget

  • Providers with MRI systems can reduce staffing costs and free up valuable MRI time for other procedures.
  • Research indicates a 53% reduction in equipment costs in addition to 59% reduced staffing costs compared to breast MRI 4 .
phy-new-seno-bright-hd-thumbnails-senobright-hd_reduce-your-diagnostic-cost-thumbnail3.jpg

Exceptionally clear visualization

Localize known or suspicious lesions with iodine contrast.
 

The SenoBright HD contrast agent highlights areas of unusual blood flow. SenoBright uses multiple x-ray exposures to reduce background signal, effectively highlighting contrast enhanced areas.
 

Two images per view are provided. A low energy image uses standard mammographic techniques and represents tissue density. The recombined image is a contrast- enhanced image in exactly the same position

Downloads

SenoBright™ Infographic
SenoBright whitepaper
Tips on successful implementation of CESM in your practice
Footnotes
  • Tardivel et al, Added Value of Contrast-Enhanced Spectral Mammography in Post-Screening Assessment; The Breast Journal, 2016 1–9; © 2016 Wiley Periodicals, Inc., 1075- 122X/16
  • https://www.breastcancer.org/research-news/20091222
  • Hobbs et al, JMed Imaging Radiat Pncol. 2015
  • Patel et al, AAJR Am J Roentgenol. 2017
  • 5 Daniaux et al. Arch Gynecol Obstet , 2015
  • 6 Data on file at GE Healthcare
Contact Us

We're ready to support you in your moments that matter. For service assistance, call us.

Thank you!

We received your request for assistance.

A GE Healthcare specialist will be reaching out shortly.

Something went wrong

We will check and get back.

JB09963XX April 2023